UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Characterization of antibodies in human immunoglobulin products from different regions worldwide

International journal of infectious diseases, 2021-03, Vol.104, p.610-616

2021

Volltextzugriff (PDF)

Human mesenchymal stem cells maintain their phenotype, multipotentiality, and genetic stability when cultured using a defined xeno-free human plasma fraction

Stem cell research & therapy, 2017-04, Vol.8 (1), p.103-103, Article 103

2017

Volltextzugriff (PDF)

Characterization of the Components and Functional Properties of a Plasma-Derived Fibrin Sealant

Plasmatology, 2023-01, Vol.17

2023

Volltextzugriff (PDF)

The burden of inhibitors in haemophilia patients

Thrombosis and haemostasis, 2016, Vol.116 Suppl 1 (S 01), p.S10-S17

2016

Volltextzugriff (PDF)

Increased Albumin Oxidation in Cerebrospinal Fluid and Plasma from Alzheimer's Disease Patients

Journal of Alzheimer's disease, 2018-01, Vol.63 (4), p.1395-1404

2018

Volltextzugriff (PDF)

Abnormal expression of type 1 plasminogen activator inhibitor and tissue factor in severe preeclampsia

Thrombosis and haemostasis, 1998-03, Vol.79 (3), p.500-508

1998

Volltextzugriff (PDF)

RELATIONSHIP OF ALBUMIN GLYCATION WITH Aβ42 AND TAU BIOMARKERS IN CSF FROM ALZHEIMER’S DISEASE PATIENTS AND HEALTHY CONTROLS

Alzheimer's & dementia, 2019-07, Vol.15 (7), p.P998-P998

2019

Volltextzugriff (PDF)

P3‐177: RELATIONSHIP OF ALBUMIN GLYCATION WITH Aβ42 AND TAU BIOMARKERS IN CSF FROM ALZHEIMER'S DISEASE PATIENTS AND HEALTHY CONTROLS

Alzheimer's & dementia, 2019-07, Vol.15, p.P998-P998

2019

Volltextzugriff (PDF)

P3‐177: RELATIONSHIP OF ALBUMIN GLYCATION WITH Aβ 42 AND TAU BIOMARKERS IN CSF FROM ALZHEIMER'S DISEASE PATIENTS AND HEALTHY CONTROLS

Alzheimer's & dementia, 2019-07, Vol.15 (7S_Part_19)

2019

Volltextzugriff (PDF)

Plasma‐derived FVIII/VWF complex shows higher protection against inhibitors than isolated FVIII after infusion in haemophilic patients: A translational study

Haemophilia : the official journal of the World Federation of Hemophilia, 2022-09, Vol.28 (5), p.737-744

2022

Volltextzugriff (PDF)

VWF Modulates the in Vivo FVIII Recovery of Different FVIII Concentrates in a Mice Model of Severe Hemophilia with Inhibitors

Blood, 2014-12, Vol.124 (21), p.2826-2826

2014

Volltextzugriff (PDF)

P3‐240: ALBUMIN OXIDATION IN CSF FROM ALZHEIMER'S DISEASE PATIENTS IS ASSOCIATED WITH ABETA‐42 AND TAU BIOMARKERS AND APOE GENOTYPE

Alzheimer's & dementia, 2018-07, Vol.14 (7S_Part_22), p.P1164-P1164

2018

Volltextzugriff (PDF)

ALBUMIN OXIDATION IN CSF FROM ALZHEIMER’S DISEASE PATIENTS IS ASSOCIATED WITH ABETA-42 AND TAU BIOMARKERS AND APOE GENOTYPE

Alzheimer's & dementia, 2018-07, Vol.14 (7), p.P1164-P1164

2018

Volltextzugriff (PDF)

MODIFICATIONS IN ALBUMIN MOLECULAR PROFILE IN A PHASE 2 STUDY BASED ON THERAPEUTIC PLASMA EXCHANGE AND 5% ALBUMIN REPLACEMENT IN ALZHEIMER'S DISEASE

Alzheimer's & dementia, 2016-07, Vol.12 (7), p.P633-P634

2016

Volltextzugriff (PDF)

P2‐067: Modifications in Albumin Molecular Profile in a Phase 2 Study Based on Therapeutic Plasma Exchange and 5% Albumin Replacement in Alzheimer's Disease

Alzheimer's & dementia, 2016-07, Vol.12 (7S_Part_13), p.P633-P634

2016

Volltextzugriff (PDF)

ALBUMIN OXIDATION STATUS IN CSF AND PLASMA SAMPLES FROM ALZHEIMER’S DISEASE PATIENTS

Alzheimer's & dementia, 2017-07, Vol.13 (7), p.P711-P711

2017

Volltextzugriff (PDF)

Lipoprotein(a) levels and isoforms and fibrinolytic activity in postmenopause--influence of hormone replacement therapy

Thrombosis and haemostasis, 1999-01, Vol.81 (1), p.104-110

1999

Volltextzugriff (PDF)

PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects

British journal of haematology, 2000-10, Vol.111 (1), p.122-128

2000

Volltextzugriff (PDF)

The effect of estrogen replacement therapy with or without progestogen on the fibrinolytic system and coagulation inhibitors in postmenopausal status

American journal of obstetrics and gynecology, 1995-12, Vol.173 (6), p.1849-1854

1995

Volltextzugriff (PDF)

Decreased expression of PAI-2 mRNA and protein in pregnancies complicated with intrauterine fetal growth retardation

Thrombosis and haemostasis, 1996, Vol.76 (5), p.761-767

1996

Volltextzugriff (PDF)

PAI‐1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects

British journal of haematology, 2000-10, Vol.111 (1), p.122-128

2000

Volltextzugriff (PDF)

Factor V Leiden and antibodies against phospholipids and protein S in a young woman with recurrent thromboses and abortion

Haematologica (Roma), 1999-01, Vol.84 (1), p.80

1999

Volltextzugriff (PDF)

Abnormal expression of plasminogen activator inhibitors in patients with gestational trophoblastic disease

The American journal of pathology, 1996-10, Vol.149 (4), p.1229-1239

1996

Volltextzugriff (PDF)

Factor IX

Production of Plasma Proteins for Therapeutic Use, 2013, p.81-92

2013

Volltextzugriff (PDF)

Evaluation of plasminogen activators and plasminogen activator inhibitors in plasma and amniotic fluid in pregnancies complicated with intrauterine fetal growth retardation

Gynecologic and obstetric investigation, 1994-01, Vol.38 (3), p.157-162

1994

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(25)
Buchkapitel
(1)

Sprache

Englisch
(26)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(14)
Science & Technology
(14)
Humans
(13)
Female
(10)
Adult
(7)
Biological And Medical Sciences
(7)
Hematology
(7)
Medical Sciences
(6)
Fibrinolysis
(5)
Middle Aged
(5)
Pregnancy
(5)
Aged
(4)
Cardiovascular System & Cardiology
(3)
Diseases Of Mother, Fetus And Pregnancy
(3)
Gynecology. Andrology. Obstetrics
(3)
Male
(3)
Peripheral Vascular Disease
(3)
Pregnancy. Fetus. Placenta
(3)
Abortion, Habitual - Etiology
(2)
Albumin
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Characterization of antibodies in human immunoglobulin products from different regions worldwide

Human mesenchymal stem cells maintain their phenotype, multipotentiality, and genetic stability when cultured using a defined xeno-free human plasma fraction

Characterization of the Components and Functional Properties of a Plasma-Derived Fibrin Sealant

The burden of inhibitors in haemophilia patients

Increased Albumin Oxidation in Cerebrospinal Fluid and Plasma from Alzheimer's Disease Patients

Abnormal expression of type 1 plasminogen activator inhibitor and tissue factor in severe preeclampsia

RELATIONSHIP OF ALBUMIN GLYCATION WITH Aβ42 AND TAU BIOMARKERS IN CSF FROM ALZHEIMER’S DISEASE PATIENTS AND HEALTHY CONTROLS

P3‐177: RELATIONSHIP OF ALBUMIN GLYCATION WITH Aβ42 AND TAU BIOMARKERS IN CSF FROM ALZHEIMER'S DISEASE PATIENTS AND HEALTHY CONTROLS

P3‐177: RELATIONSHIP OF ALBUMIN GLYCATION WITH Aβ 42 AND TAU BIOMARKERS IN CSF FROM ALZHEIMER'S DISEASE PATIENTS AND HEALTHY CONTROLS

Plasma‐derived FVIII/VWF complex shows higher protection against inhibitors than isolated FVIII after infusion in haemophilic patients: A translational study

VWF Modulates the in Vivo FVIII Recovery of Different FVIII Concentrates in a Mice Model of Severe Hemophilia with Inhibitors

P3‐240: ALBUMIN OXIDATION IN CSF FROM ALZHEIMER'S DISEASE PATIENTS IS ASSOCIATED WITH ABETA‐42 AND TAU BIOMARKERS AND APOE GENOTYPE

ALBUMIN OXIDATION IN CSF FROM ALZHEIMER’S DISEASE PATIENTS IS ASSOCIATED WITH ABETA-42 AND TAU BIOMARKERS AND APOE GENOTYPE

MODIFICATIONS IN ALBUMIN MOLECULAR PROFILE IN A PHASE 2 STUDY BASED ON THERAPEUTIC PLASMA EXCHANGE AND 5% ALBUMIN REPLACEMENT IN ALZHEIMER'S DISEASE

P2‐067: Modifications in Albumin Molecular Profile in a Phase 2 Study Based on Therapeutic Plasma Exchange and 5% Albumin Replacement in Alzheimer's Disease

ALBUMIN OXIDATION STATUS IN CSF AND PLASMA SAMPLES FROM ALZHEIMER’S DISEASE PATIENTS

Lipoprotein(a) levels and isoforms and fibrinolytic activity in postmenopause--influence of hormone replacement therapy

PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects

The effect of estrogen replacement therapy with or without progestogen on the fibrinolytic system and coagulation inhibitors in postmenopausal status

Decreased expression of PAI-2 mRNA and protein in pregnancies complicated with intrauterine fetal growth retardation

PAI‐1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects

Factor V Leiden and antibodies against phospholipids and protein S in a young woman with recurrent thromboses and abortion

Abnormal expression of plasminogen activator inhibitors in patients with gestational trophoblastic disease

Factor IX

Evaluation of plasminogen activators and plasminogen activator inhibitors in plasma and amniotic fluid in pregnancies complicated with intrauterine fetal growth retardation

Suchergebnisse filtern